Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Annexa-S: Andexanet Alfa for Urgent Surgery
NCT04233073Phase 2Terminated
- Sponsor
- Alexion Pharmaceuticals
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 2 trial of andexanet alfa in hemorrhage, anticoagulant reversal, sponsored by Alexion Pharmaceuticals. Started Jun 2021; status: terminated.
02
Drugs
andexanet alfa
03
Conditions
hemorrhageanticoagulant reversal
Beyond the preview
Go deeper on NCT04233073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04233073.